Bard
Bard Havre, Oslo NO
Patent application number | Description | Published |
---|---|---|
20090131211 | DEVICE FOR TRANSMISSION OF A TORQUE - Fluid-tight transmission comprising an internal cogwheel ( | 05-21-2009 |
Bard Indrevall, Oslo NO
Patent application number | Description | Published |
---|---|---|
20130149241 | PEPTIDE RADIOTRACER COMPOSITIONS - The present invention relates to imaging agent compositions comprising radiolabelled c-Met binding peptides suitable for positron emission tomography (PET) imaging in vivo. The c-Met binding peptides are labelled with the radioisotope | 06-13-2013 |
Bard Indrevoll, Oslo NO
Patent application number | Description | Published |
---|---|---|
20090203584 | Peptide-based Compounds - The invention relates to new peptide-based compounds for use as diagnostic imaging agents or as therapeutic agents wherein the agents comprise targeting vectors which bind to integrin receptors. | 08-13-2009 |
20120020882 | PEPTIDE-BASED COMPOUNDS - The invention relates to new peptide-based compounds for use as diagnostic imaging agents or as therapeutic agents wherein the agents comprise targeting vectors which bind to integrin receptors. | 01-26-2012 |
20130189186 | APOPTOSIS IMAGING AGENTS BASED ON LANTIBIOTIC PEPTIDES - The present invention relates to radiopharmaceutical imaging in vivo of apoptosis. The invention provides imaging agents which target apoptotic cells via selective binding to the aminophospholipid phosphatidylethanolamine (PE), which is exposed on the surface of apoptotic cells. The radiopharmaceuticals comprise radiometal complexes of chelator conjugates of PE-binding peptides. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging. | 07-25-2013 |
20130251632 | APOPTOSIS PET IMAGING AGENTS - The present invention relates to radiopharmaceutical imaging in vivo of apoptosis and other forms of cell death. The invention provides PET imaging agents which target apoptotic cells via selective binding to the aminophospholipid phosphatidylethanolamine (PE), which is exposed on the surface of apoptotic cells. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging. | 09-26-2013 |
20130259803 | RADIOCONJUGATION METHOD - The present invention relates to the field of radiopharmaceuticals for in vivo imaging, in particular to a method of labelling a biological targeting molecule with a radioisotope. The method of the invention is particularly suitable for use with an automated synthesizer apparatus. Also provided are precursors in sterile form, as well as cassettes comprising such precursors useful in the method. | 10-03-2013 |
20130343990 | RADIOLABELLED OCTREOTATE ANALOGUES AS PET TRACERS - Novel radiotracer(s) for Positron Emission Tomography (PET) imaging are described. Novel radiotracer(s) for Positron Emission Tomography (PET) imaging of neuorendocrine tumors are described. Specifically the present invention describes novel [18F]Fluoroethyltriazol-[Tyr3]Octreotate analogs; in particular those that target somatostatin receptors found on the cell surface of gastroenteropancreatic neuorendocrine tumors. The present invention also describes intermediate(s), precursor(s), pharmaceutical composition(s), methods of making, and methods of use of the novel radiotracer(s). | 12-26-2013 |
20140004041 | TECHNETIUM LABELLED PEPTIDES | 01-02-2014 |
Bard Indrevoll, Olso NO
Patent application number | Description | Published |
---|---|---|
20130295010 | HER2 BINDING PEPTIDES LABELLED WITH A 18F - CONTAINING ORGANOSILICON COMPOUND - Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents. | 11-07-2013 |
Bard Tinnen, Stavanger NO
Patent application number | Description | Published |
---|---|---|
20150027715 | FLOW CONTROL DEVICE AND METHOD - The flow control device includes a flow path, a compensation chamber and a regulator assembly defining a first surface exposed to the flow path and an opposing second surface which is exposed to the compensation chamber. A drive arrangement is provided for moving the regulator assembly to vary the flow path. Fluid flowing through the flow path establishes a pressure which varies across the first surface of the regulator assembly. The compensation chamber is in pressure communication with a localised region of the first surface which is selected to establish a compensation chamber pressure which acts against the second surface of the regulator assembly to bias the regulator assembly in a desired direction. The first surface of the regulator assembly may define a profile configured to minimise the variation in pressure applied over the first surface by action of fluid flowing through the flow path. | 01-29-2015 |
Bard Vestgard, Lier NO
Patent application number | Description | Published |
---|---|---|
20090121466 | Releasable holding mechanism and method of use - The invention relates to a releasable holding mechanism which may be used to hold and release a roll bar in a roll over protection system. The roll bar is often made part of the seat structure of vehicle, or a part of the chassis of the vehicle. The releasable holding mechanism will be fastened rigidly or slightly loose to the roll bar frame, seat frame or the chassis of the vehicle. Between the roll bar and the releasable holding mechanism there will be a connection element that is rigidly or slightly loosely fastened to the roll bar. The arrangement of fastening the connection element rigidly or slightly loosely depends on the tolerances for positioning the actuator towards the roll bar. The connection element is locked or released by the releasable holding mechanism. The releasable holding mechanism is locked/-engaged when the roll bar is pushed downwards whereby the connection element is forced into the releasable holding mechanism. The releasable holding mechanism is to release the connecting element when a signal is sent to the release element of the holding mechanism. The releasable holding mechanism can be activated by one short duration pulse, for instance a pulse from an electronic control unit for activation of airbags in a vehicle. The system can be activated with low energy demands. | 05-14-2009 |